Table 3.
THA | Multiple-dose TXA (N = 65) | Single-dose TXA (N = 128) | P value |
Age (years) | 65.52 ± 14.30 | 64.84 ± 14.16 | 0.754 |
Gender (male/female) | 29/36 | 54/74 | 0.761 |
Height (m) | 1.62 ± 0.69 | 1.60 ± 0.07 | 0.087 |
Weight (kg) | 61.38 ± 9.36 | 58.74 ± 10.14 | 0.095 |
BMI (kg/m2) | 23.49 ± 3.26 | 22.94 ± 3.62 | 0.327 |
Drink | 20/65 | 29/128 | 0.294 |
Smoke | 21/65 | 28/128 | 0.161 |
Diagnosis | |||
AVN | 20 | 34 | 0.816 |
DDH | 13 | 28 | |
FNF | 20 | 46 | |
ITF | 2 | 6 | |
OA | 6 | 9 | |
RA | 3 | 5 | |
FAI | 1 | 0 | |
ASA grade | 2.50 ± 0.72 | 2.38 ± 0.65 | 0.215 |
Operated side (left/right) | 29/36 | 74/54 | 0.094 |
Operation time (min) | 84.00 ± 29.32 | 80.34 ± 30.71 | 0.428 |
Length of hospital stay | 14.63 ± 7.08 | 14.93 ± 9.01 | 0.816 |
Postoperative hospital stay | 8.65 ± 6.49 | 9.27 ± 8.15 | 0.595 |
TKA | Multiple-dose TXA (N = 70) | Single-dose TXA (N = 96) | P value |
Age (years) | 68.33 ± 7.40 | 67.28 ± 8.53 | 0.411 |
Gender (male/female) | 11/59 | 26/70 | 0.092 |
Height (m) | 1.57 ± 0.06 | 1.58 ± 0.06 | 0.542 |
Weight (kg) | 63.19 ± 9.44 | 60.97 ± 9.68 | 0.157 |
BMI (kg/m2) | 25.66 ± 3.34 | 24.48 ± 3.92 | 0.057 |
Diagnosis | |||
OA | 66 | 83 | 0.244 |
RA | 4 | 11 | |
GA | 0 | 2 | |
ASA grade | 2.27 ± 0.48 | 2.17 ± 0.52 | 0.176 |
Operated side (left/right) | 36/34 | 36/60 | 0.083 |
Operation time (min) | 94.61 ± 28.07 | 95.54 ± 28.63 | 0.836 |
Length of hospital stay | 14.87 ± 8.16 | 14.98 ± 6.60 | 0.925 |
Postoperative hospital stay | 8.49 ± 7.40 | 8.94 ± 5.51 | 0.653 |
ASA American Society of Anesthesiologists physical status classification system, AVN avascular necrosis, BMI body mass index, DDH developmental dysplasia of the hip, FAI femoroacetabular impingement, FNF femoral neck fracture, GA gout arthritis, ITF intertrochanteric fracture, OA osteoarthritis, RA rheumatoid arthritis, THA total hip arthroplasty, TKA total knee arthroplasty, TXA tranexamic acid